(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1321062 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of G2E3 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions ISO RGD:1321063 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of G2E3 mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression ISO RGD:1321063 6480464 1, 2-Dimethylhydrazine results in decreased expression of G2E3 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO RGD:1321062 6480464 Estradiol results in increased expression of G2E3 mRNA CTD PMID:19167446 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1321063 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1321063 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1321062 6480464 Tetrachlorodibenzodioxin affects the expression of G2E3 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of G2E3 mRNA CTD PMID:32109520 , PMID:33387578 4-hydroxyphenyl retinamide increases expression ISO RGD:1321063 6480464 Fenretinide results in increased expression of G2E3 mRNA CTD PMID:28973697 acetamide increases expression EXP 6480464 acetamide results in increased expression of G2E3 mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of G2E3 mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO RGD:1321063 6480464 Aflatoxin B1 results in increased expression of G2E3 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:1321062 6480464 Aflatoxin B1 results in decreased methylation of G2E3 gene CTD PMID:27153756 aflatoxin M1 decreases expression ISO RGD:1321062 6480464 Aflatoxin M1 results in decreased expression of G2E3 mRNA CTD PMID:30928695 all-trans-retinoic acid decreases expression ISO RGD:1321062 6480464 Tretinoin results in decreased expression of G2E3 mRNA CTD PMID:21934132 antirheumatic drug increases expression ISO RGD:1321062 6480464 Antirheumatic Agents results in increased expression of G2E3 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1321062 6480464 aristolochic acid I results in decreased expression of G2E3 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:1321062 6480464 arsenite inhibits the reaction [G3BP1 protein binds to G2E3 mRNA] CTD PMID:32406909 atrazine decreases expression ISO RGD:1321062 6480464 Atrazine results in decreased expression of G2E3 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:1321062 6480464 Benzo(a)pyrene results in decreased expression of G2E3 mRNA CTD PMID:21632981 , PMID:22316170 benzo[a]pyrene decreases methylation ISO RGD:1321062 6480464 Benzo(a)pyrene results in decreased methylation of G2E3 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1321062 6480464 7 more ... CTD PMID:20018196 , PMID:20382639 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of G2E3 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of G2E3 mRNA CTD PMID:34947998 butanal decreases expression ISO RGD:1321062 6480464 butyraldehyde results in decreased expression of G2E3 mRNA CTD PMID:26079696 cadmium atom multiple interactions ISO RGD:1321062 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of G2E3 mRNA CTD PMID:35301059 cadmium dichloride increases expression ISO RGD:1321062 6480464 Cadmium Chloride results in increased expression of G2E3 mRNA CTD PMID:26472689 cadmium dichloride multiple interactions ISO RGD:1321062 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of G2E3 mRNA CTD PMID:35301059 calcitriol decreases expression ISO RGD:1321062 6480464 Calcitriol results in decreased expression of G2E3 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1321062 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of G2E3 mRNA CTD PMID:21592394 carbamazepine affects expression ISO RGD:1321062 6480464 Carbamazepine affects the expression of G2E3 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1321063 6480464 Nanotubes, Carbon results in increased expression of G2E3 mRNA CTD PMID:25554681 cisplatin increases expression ISO RGD:1321063 6480464 Cisplatin results in increased expression of G2E3 mRNA CTD PMID:21151649 cisplatin decreases expression ISO RGD:1321062 6480464 Cisplatin results in decreased expression of G2E3 mRNA CTD PMID:27392435 , PMID:27594783 cisplatin multiple interactions ISO RGD:1321062 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of G2E3 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1321063 6480464 Cisplatin results in decreased expression of G2E3 mRNA CTD PMID:25270620 copper atom increases expression EXP 6480464 Copper deficiency results in increased expression of G2E3 mRNA CTD PMID:26033743 copper(0) increases expression EXP 6480464 Copper deficiency results in increased expression of G2E3 mRNA CTD PMID:26033743 coumestrol multiple interactions ISO RGD:1321062 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G2E3 mRNA CTD PMID:19167446 coumestrol increases expression ISO RGD:1321062 6480464 Coumestrol results in increased expression of G2E3 mRNA CTD PMID:19167446 cyclosporin A increases expression ISO RGD:1321062 6480464 Cyclosporine results in increased expression of G2E3 mRNA CTD PMID:25562108 dicrotophos decreases expression ISO RGD:1321062 6480464 dicrotophos results in decreased expression of G2E3 mRNA CTD PMID:28302478 dorsomorphin multiple interactions ISO RGD:1321062 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1321062 6480464 Doxorubicin results in decreased expression of G2E3 mRNA CTD PMID:29803840 doxorubicin multiple interactions ISO RGD:1321063 6480464 [Doxorubicin co-treated with Folic Acid] results in increased expression of G2E3 mRNA CTD PMID:28608983 Enterolactone multiple interactions ISO RGD:1321062 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of G2E3 mRNA CTD PMID:19167446 folic acid multiple interactions ISO RGD:1321063 6480464 [Doxorubicin co-treated with Folic Acid] results in increased expression of G2E3 mRNA CTD PMID:28608983 formaldehyde decreases expression ISO RGD:1321062 6480464 Formaldehyde results in decreased expression of G2E3 mRNA CTD PMID:23649840 glycidol increases expression EXP 6480464 glycidol results in increased expression of G2E3 mRNA CTD PMID:24915197 gold atom decreases expression ISO RGD:1321062 6480464 Gold results in decreased expression of G2E3 mRNA CTD PMID:25523186 gold(0) decreases expression ISO RGD:1321062 6480464 Gold results in decreased expression of G2E3 mRNA CTD PMID:25523186 hydrogen peroxide increases expression ISO RGD:1321062 6480464 Hydrogen Peroxide results in increased expression of G2E3 mRNA CTD PMID:18951874 inulin multiple interactions ISO RGD:1321063 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of G2E3 mRNA CTD PMID:36331819 irinotecan decreases expression ISO RGD:1321062 6480464 Irinotecan analog results in decreased expression of G2E3 mRNA CTD PMID:18927307 menadione decreases expression ISO RGD:1321063 6480464 Vitamin K 3 results in decreased expression of G2E3 mRNA CTD PMID:25270620 ochratoxin A increases expression ISO RGD:1321062 6480464 ochratoxin A results in increased expression of G2E3 mRNA CTD PMID:30559759 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of G2E3 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of G2E3 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1321063 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of G2E3 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of G2E3 mRNA CTD PMID:34911549 paracetamol increases expression ISO RGD:1321062 6480464 Acetaminophen results in increased expression of G2E3 mRNA CTD PMID:22230336 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of G2E3 mRNA CTD PMID:33387578 PCB138 multiple interactions ISO RGD:1321063 6480464 [2 more ... CTD PMID:25510870 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1321062 6480464 perfluorooctane sulfonic acid results in decreased expression of G2E3 mRNA CTD PMID:27153767 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1321063 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of G2E3 mRNA, [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of G2E3 mRNA CTD PMID:36331819 phenobarbital decreases expression ISO RGD:1321063 6480464 Phenobarbital results in decreased expression of G2E3 mRNA CTD PMID:23091169 phenylmercury acetate decreases expression ISO RGD:1321062 6480464 Phenylmercuric Acetate results in decreased expression of G2E3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1321062 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of G2E3 mRNA CTD PMID:27188386 potassium chromate multiple interactions ISO RGD:1321062 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of G2E3 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1321062 6480464 potassium chromate(VI) results in decreased expression of G2E3 mRNA CTD PMID:22079256 quercetin decreases expression ISO RGD:1321062 6480464 Quercetin results in decreased expression of G2E3 mRNA CTD PMID:21632981 resveratrol increases expression ISO RGD:1321062 6480464 resveratrol results in increased expression of G2E3 mRNA CTD PMID:19167446 SB 431542 multiple interactions ISO RGD:1321062 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 succimer multiple interactions ISO RGD:1321063 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of G2E3 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of G2E3 mRNA CTD PMID:21641980 , PMID:26378955 sunitinib decreases expression ISO RGD:1321062 6480464 Sunitinib results in decreased expression of G2E3 mRNA CTD PMID:31533062 testosterone multiple interactions ISO RGD:1321062 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of G2E3 mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1321062 6480464 Testosterone results in decreased expression of G2E3 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:1321063 6480464 Carbon Tetrachloride results in increased expression of G2E3 mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of G2E3 mRNA CTD PMID:23411599 , PMID:34492290 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of G2E3 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of G2E3 mRNA CTD PMID:25729387 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of G2E3 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1321062 6480464 trichostatin A results in decreased expression of G2E3 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1321062 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of G2E3 mRNA CTD PMID:27188386 trimellitic anhydride increases expression ISO RGD:1321063 6480464 trimellitic anhydride results in increased expression of G2E3 mRNA CTD PMID:19042947 trovafloxacin decreases expression ISO RGD:1321063 6480464 trovafloxacin results in decreased expression of G2E3 mRNA CTD PMID:35537566 tungsten increases expression ISO RGD:1321063 6480464 Tungsten results in increased expression of G2E3 mRNA CTD PMID:30912803 valproic acid increases expression ISO RGD:1321062 6480464 Valproic Acid results in increased expression of G2E3 mRNA CTD PMID:29154799 valproic acid decreases expression ISO RGD:1321062 6480464 Valproic Acid results in decreased expression of G2E3 mRNA CTD PMID:23179753 , PMID:27188386 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of G2E3 mRNA CTD PMID:23034163 vorinostat decreases expression ISO RGD:1321062 6480464 vorinostat results in decreased expression of G2E3 mRNA CTD PMID:27188386 zinc atom multiple interactions ISO RGD:1321062 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of G2E3 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1321062 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of G2E3 mRNA CTD PMID:18593933